The Safety Profile Playbook: Advancing Dosage Optimisation & Safety Assessment Strategies for Therapeutic Radiopharmaceutical Development

• Exploring evolving approaches to dosage optimisation during therapeutic radiopharmaceutical development to improve therapeutic index whilst maintaining patient safety 
• Assessing how dosimetry, renal safety evaluation and longitudinal toxicity monitoring can be more effectively integrated into clinical development strategy and regulatory decision-making 
• Discussing opportunities to modernise safety assessment frameworks for radiopharmaceutical therapies in line with emerging clinical data, novel isotopes and next-generation treatment paradigms

Speakers: